Skeletal Dysplasia Account Manager (Central Region)

Role: Skeletal Dysplasia Account Manager driving the launch of Infigratinib for achondroplasia, focusing on clinical expertise and territory growth. Responsibilities: develop strategic territory plans targeting healthcare providers in genetics, pediatrics, and orthopedics; build relationships with KOLs; educate stakeholders on Infigratinib and skeletal dysplasia; collaborate with cross-functional teams including Medical and Marketing; ensure compliance and execute company initiatives. Requirements: 8–10 years in pharma/biotech, 4+ years in rare/genetic diseases, experience in product launches, BS/BA required (MBA preferred). Skills: clinical knowledge of achondroplasia, strong account management, influence, communication, and strategic planning skills; high proficiency with AI tools and ethics-focused. High-Value: rare pediatric disease, skeletal dysplasia, product launch, cross-functional collaboration, extensive travel within the central US region. Work setup: remote/hybrid with extensive travel.